A detailed history of Ameriprise Financial Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 229,497 shares of HAE stock, worth $18.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
229,497
Previous 272,500 15.78%
Holding current value
$18.4 Million
Previous $23.3 Million 18.36%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$81.24 - $97.37 $3.49 Million - $4.19 Million
-43,003 Reduced 15.78%
229,497 $19 Million
Q1 2024

May 15, 2024

SELL
$71.24 - $85.35 $1.04 Million - $1.24 Million
-14,560 Reduced 5.07%
272,500 $23.3 Million
Q4 2023

Feb 14, 2024

SELL
$80.59 - $92.61 $8.04 Million - $9.24 Million
-99,746 Reduced 25.79%
287,060 $24.5 Million
Q3 2023

Nov 14, 2023

SELL
$82.56 - $93.49 $101,796 - $115,273
-1,233 Reduced 0.32%
386,806 $34.7 Million
Q2 2023

Aug 14, 2023

SELL
$80.84 - $89.45 $5.84 Million - $6.46 Million
-72,203 Reduced 15.69%
388,039 $33 Million
Q1 2023

May 15, 2023

BUY
$72.75 - $90.6 $1.05 Million - $1.3 Million
14,366 Added 3.22%
460,242 $38.1 Million
Q4 2022

Feb 14, 2023

SELL
$73.85 - $86.14 $540,729 - $630,717
-7,322 Reduced 1.62%
445,876 $35.1 Million
Q3 2022

Nov 14, 2022

BUY
$63.3 - $78.66 $3.49 Million - $4.34 Million
55,121 Added 13.85%
453,198 $33.6 Million
Q2 2022

Aug 15, 2022

BUY
$49.27 - $66.08 $11.1 Million - $14.8 Million
224,492 Added 129.33%
398,077 $25.9 Million
Q1 2022

May 16, 2022

BUY
$43.77 - $63.22 $4.47 Million - $6.45 Million
102,015 Added 142.54%
173,585 $11 Million
Q4 2021

Feb 14, 2022

SELL
$49.55 - $74.59 $119,118 - $179,314
-2,404 Reduced 3.25%
71,570 $3.8 Million
Q3 2021

Nov 15, 2021

SELL
$57.6 - $70.59 $2.09 Million - $2.56 Million
-36,216 Reduced 32.87%
73,974 $5.22 Million
Q2 2021

Aug 16, 2021

SELL
$51.81 - $118.56 $33.4 Million - $76.5 Million
-645,234 Reduced 85.41%
110,190 $7.34 Million
Q1 2021

May 17, 2021

BUY
$111.01 - $139.48 $10.7 Million - $13.4 Million
96,006 Added 14.56%
755,424 $83.9 Million
Q4 2020

Feb 12, 2021

BUY
$88.75 - $119.95 $15.4 Million - $20.8 Million
173,686 Added 35.76%
659,418 $78.3 Million
Q3 2020

Nov 16, 2020

BUY
$75.65 - $93.58 $4.9 Million - $6.06 Million
64,746 Added 15.38%
485,732 $42.4 Million
Q2 2020

Aug 14, 2020

BUY
$84.96 - $118.91 $2.66 Million - $3.72 Million
31,254 Added 8.02%
420,986 $37.7 Million
Q1 2020

May 15, 2020

BUY
$74.34 - $121.82 $20.5 Million - $33.7 Million
276,340 Added 243.7%
389,732 $38.8 Million
Q4 2019

Feb 14, 2020

SELL
$114.37 - $129.46 $1.55 Million - $1.75 Million
-13,519 Reduced 10.65%
113,392 $13 Million
Q3 2019

Nov 14, 2019

SELL
$117.16 - $138.52 $1.47 Million - $1.73 Million
-12,516 Reduced 8.98%
126,911 $16 Million
Q2 2019

Aug 14, 2019

SELL
$81.74 - $120.34 $18.9 Million - $27.9 Million
-231,732 Reduced 62.43%
139,427 $16.8 Million
Q1 2019

May 15, 2019

SELL
$83.25 - $102.12 $5.35 Million - $6.56 Million
-64,252 Reduced 14.76%
371,159 $32.5 Million
Q4 2018

Feb 14, 2019

BUY
$90.66 - $116.63 $839,874 - $1.08 Million
9,264 Added 2.17%
435,411 $43.6 Million
Q3 2018

Nov 14, 2018

SELL
$89.96 - $114.58 $20.7 Million - $26.3 Million
-229,627 Reduced 35.02%
426,147 $48.8 Million
Q2 2018

Aug 14, 2018

SELL
$71.53 - $95.75 $41.4 Million - $55.4 Million
-578,215 Reduced 46.86%
655,774 $58.8 Million
Q1 2018

May 15, 2018

BUY
$60.72 - $74.41 $41.2 Million - $50.5 Million
678,660 Added 122.21%
1,233,989 $90.3 Million
Q4 2017

Feb 12, 2018

SELL
$44.96 - $58.99 $1.05 Million - $1.38 Million
-23,388 Reduced 4.04%
555,329 $32.3 Million
Q3 2017

Nov 07, 2017

BUY
$40.38 - $44.87 $23.4 Million - $26 Million
578,717
578,717 $26 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.12B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.